PhRMA’s star power
Actor Michael J. Fox is scheduled to deliver the closing keynote address during the Pharmaceutical Research & Manufacturers of America annual meeting April 3 in Palm Beach, Fla. Fox recently returned to acting after seeing improvement in his symptoms of Parkinson's disease. Fox credits his improvement to a new medication he recently began taking; in media interviews, Fox has declined to name the product...
You may also be interested in...
With a late-stage compound on its hands, MGB is currently in discussions with several biotech and pharma companies and also with venture capitalists to continue late-stage development of a novel antibiotic which could transform treatment of Clostridium difficile.
AZ and the EU are at loggerheads over supplies of the COVID-19 vaccine. On top of that, its marketing authorization will present dilemmas.
The European Medicines Agency is expected to decide soon whether Amarin’s fish oil pill, Vascepa, should win pan-EU marketing approval for reducing cardiovascular risk.